Public Profile

Glaukos

Glaukos Corporation, a pioneering force in the ophthalmic industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1998, Glaukos has established itself as a leader in developing innovative therapies for glaucoma and other eye diseases. The company is renowned for its unique micro-invasive surgical procedures, particularly the iStent® technology, which has transformed the treatment landscape for patients suffering from glaucoma. With a commitment to advancing eye care, Glaukos has achieved notable milestones, including the first FDA approval of a micro-invasive glaucoma surgery device. The company’s dedication to research and development has positioned it at the forefront of the ophthalmic market, making significant contributions to improving patient outcomes and enhancing the quality of life for those affected by vision-related conditions.

DitchCarbon Score

How does Glaukos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Glaukos's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Glaukos's reported carbon emissions

In 2022, Glaukos, headquartered in the US, reported no specific carbon emissions data in kg CO2e. The company has not disclosed any Scope 1, 2, or 3 emissions figures, nor have they set any formal reduction targets or climate pledges. Despite the absence of detailed emissions data, Glaukos is actively engaged in sustainability initiatives, as indicated by their focus on gas intensity and water consumption intensity metrics. Their gas intensity is approximately 0.00036161 kg CO2e per unit of revenue, while their water consumption intensity stands at about 0.00466 kg per unit of revenue. As the company continues to develop its sustainability strategies, it remains essential for Glaukos to establish clear emissions reduction targets and commitments to align with industry standards and address climate change effectively.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Glaukos's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Glaukos is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Glaukos is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Canton Chem

US
Health Services
Updated 11 days ago

Strive Pharmaceuticals Inc.

US
Health Services
Updated 11 days ago

Interpath Services Pty. Ltd.

AU
Health Services
Updated 4 days ago
CDP
UN

Hu Group Holdings

JP
Health Services
Updated 11 days ago

Pan Plast

DE
Health Services
Updated 1 day ago

Austin Chemical Company

US
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers